David Sinclair· PhD
A subset of individuals may be vulnerable to cholesterol-lowering drugs, especially if brain cholesterol or SIRT1/NAD⁺ are already altered by genetics, age, or disease
We can't find evidence that holds up here. Proponents are reasoning from mechanism or analogy rather than direct human data, and the most credible skeptics raise objections we can't dismiss.
A subset of individuals may be vulnerable to cholesterol-lowering drugs, especially if brain cholesterol or SIRT1/NAD⁺ are already altered by genetics, age, or disease
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.